Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 5.07B | 4.55B | 3.93B | 4.80B | 4.69B | 3.36B |
Gross Profit | 801.00M | 696.00M | 658.00M | 1.17B | 1.01B | 789.00M |
EBITDA | 36.57M | -187.00M | 103.00M | 209.00M | 277.00M | 160.00M |
Net Income | -306.00M | -290.00M | 4.00M | 92.00M | 150.00M | 43.00M |
Balance Sheet | ||||||
Total Assets | 3.30B | 3.41B | 1.82B | 2.04B | 2.07B | 1.87B |
Cash, Cash Equivalents and Short-Term Investments | 16.00M | 35.00M | 5.00M | 98.00M | 29.00M | 70.00M |
Total Debt | 685.00M | 664.00M | 558.00M | 617.00M | 135.00M | 116.00M |
Total Liabilities | 1.72B | 1.80B | 1.23B | 1.45B | 998.00M | 802.00M |
Stockholders Equity | 1.59B | 1.61B | 594.00M | 589.00M | 1.07B | 1.07B |
Cash Flow | ||||||
Free Cash Flow | -70.00M | -57.00M | 25.00M | 253.00M | 116.00M | -22.00M |
Operating Cash Flow | -21.00M | -12.00M | 89.00M | 310.00M | 155.00M | 25.00M |
Investing Cash Flow | -1.08B | -1.06B | -66.00M | -56.00M | -38.00M | -39.00M |
Financing Cash Flow | 1.11B | 1.11B | -117.00M | -183.00M | -158.00M | 32.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $1.82B | 10.47 | 14.25% | 0.60% | -5.69% | 51.78% | |
66 Neutral | $4.40B | 35.43 | 4.20% | 1.51% | -0.30% | -20.76% | |
59 Neutral | $1.72B | 97.96 | 1.21% | 2.01% | -7.66% | -78.26% | |
58 Neutral | $1.07B | 51.17 | 2.72% | 1.83% | -11.77% | -52.06% | |
58 Neutral | HK$14.16B | 4.53 | -3.01% | 6.82% | 3.67% | -54.16% | |
53 Neutral | $710.91M | ― | -3.44% | 0.88% | -13.10% | -121.50% | |
50 Neutral | $2.65B | ― | -27.75% | ― | 32.38% | -2221.75% |
RXO, Inc. held its 2025 Annual Meeting of Stockholders on May 21, 2025, where key decisions were made regarding the company’s governance and financial oversight. During the meeting, stockholders elected Class II and III directors for terms expiring in 2026, ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and approved an advisory resolution on executive compensation.
The most recent analyst rating on (RXO) stock is a Hold with a $19.00 price target. To see the full list of analyst forecasts on RXO, Inc. stock, see the RXO Stock Forecast page.
On May 7, 2025, RXO announced its first-quarter financial results, highlighting the successful integration of Coyote coverage operations into the RXO Connect platform. This integration is expected to yield over $70 million in cash synergies, enhancing the company’s operational efficiency. The company reported a 26% year-over-year increase in less-than-truckload brokerage volume and a 24% growth in Last Mile stops. Despite these operational successes, RXO reported a first-quarter GAAP net loss of $31 million, influenced by transaction and integration costs. The company’s revenue for the quarter was $1.4 billion, up from $913 million in the same period last year.